Wellstar/TMI Announces Pending Pressure Ulcer Study On Leg And Foot Ulcers

Wellstar International,
Inc. (OTCBB: WLSI), a provider of specialized diagnostic software and
equipment, announced today that its wholly owned subsidiary,
Trillennium Medical Imaging ("TMI"), has begun negotiations for a
pressure ulcer study focused on ulcers caused by diabetic foot and
venous legs. The Company is currently in talks with several major
teaching and research universities, the goal of which is to secure a
clinical partner for this study. Wellstar anticipates that the study
could start as early as March 2009.


In the U.S. alone, approximately 1.5 million adults are treated each
year for pressure ulcers (bedsores) with associated health care costs
of over $5 billion. Regrettably, more than 65,000 patients die each
year from complications related to these ulcers. Pressure ulcers
represent one of four of the most common and costly deficiencies
found in long-term care facilities.



A diabetic foot ulcer is a sore or wound that often occurs in people
with diabetes; these ulcers may be difficult to heal, susceptible to
infection and may lead to amputation of the affected toe, foot or leg
if not treated. Over 850,000 chronic diabetic ulcers are diagnosed in
the U.S. each year. Approximately 3 million diabetic patients will
develop an ulcer and 25% of these patients will have a foot
amputated.



Venous leg ulcer is a sore or wound that is caused by poor
circulation of blood in the veins of the legs usually caused by
faulty valves allowing pressure to build up in the veins. This
pressure causes damage to the tiny blood vessels in the skin, making
the skin become thin and inflamed, and causing the death of tissue
cells leading to the ulcer.



The Company's infrared imaging system involves the detection and
recording of skin temperature and injury patterns, providing visual
and quantitative documentation to accurately capture body temperature
data. The Company's system map changes in skin blood flow by
translating temperature data into pictures. The interpretation of
these temperatures and thermal patterns can play an important role in
detecting these sores at an early stage.



Wellstar/TMI CEO John Antonio stated, "We are looking forward to
working with one of the clinical partners that we are currently
communicating with about this planned study. Early detection of
pressure ulcers is critical and can actually help prevent ulcer
outbreaks among patients. The TMI infrared imaging system is a viable
tool, and should soon prove to be the medical standard for predicting
and preventing pressure ulcers in the medical community. "



About Wellstar International, Inc.



Wellstar International, Inc., through its wholly owned operating
subsidiary Trillennium Medical Imaging, Inc. (TMI), is poised to
become a leading diagnostic company in the health care industry. TMI
has developed and is marketing fully calibrated and functional,
thermal imaging systems that utilize state-of-the-art infrared
technologies and proprietary software to accurately and
cost-effectively measure physiological changes in the human body.
More information on the Company and its unique diagnostic software
and product line is available on Wellstar's corporate Website by
visiting: wellstar.us



Forward-Looking Statements



This press release contains statements, which may constitute
'forward-looking statements' within the meaning of the Securities Act
of 1933 and the Securities Exchange Act of 1934, as amended by the
Private Securities Litigation Reform Act of 1995. Prospective
investors are cautioned that any such forward-looking statements are
not guarantees of future performance and involve risks and
uncertainties, and that actual results may differ materially from
those contemplated by such forward-looking statements. Important
factors currently known to management that could cause actual results
to differ materially from those in forward-statements include
fluctuation of operating results, the ability to compete successfully
and the ability to complete before-mentioned transactions. The
company undertakes no obligation to update or revise forward-looking
statements to reflect changed assumptions, the occurrence of
unanticipated events or changes to future operating results.

Wellstar International, Inc.